News

Baobaole chewable tablets are a traditional Chinese medicine used to treat gastric and general abdomen discomfort. This drug stimulates appetites and promotes digestion with mild and lasting effects.

The company is operating profitably and the past twelve months revenues were approximately $58.5 million. ParadigmHealth, based in New Jersey, is a leading provider of innovative, consumer-centric decision

The BT Test is being made available to a select number of physicians in the Phoenix market as part of the company’s initial market release. The BT (biomarker

CardioVations’ product line includes the Port-Access products for performing minimally invasive cardiac valve procedures. The CardioVations product line is expected to generate sales of more than $20 million

The FDA has recently published a draft guidance on studies designed to show non-inferiority as a basis for approval of antibacterial drug products and has requested that Pfizer

The primary objective of the trial is to determine the maximum tolerated dose (MTD), dose limiting toxicity (DLT), and safety profile of Reolysin when administered intratumourally to patients

Effective upon regulatory approval of golimumab in the EU, the revised agreement will extend the duration of Schering-Plough’s rights to exclusively market Remicade in its current marketing territories

The Department of Health and Human Services (HHS) granted permission because the company has fulfilled a number of significant milestones in the contract. The income will be recognized

The trial is designed to assess the safety, tolerability and cognitive effects of three doses of MEM 3454 in patients with cognitive impairment associated with schizophrenia (CIAS). The